Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 281 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1492. Clear
Clear
Q1
MARSHALL & POPP, LLC for AMGEN USA INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q1
LUNDBECK LLC for LUNDBECK LLC
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View →
Q1
NATIONAL ALLIANCE ON MENTAL ILLNESS for NATIONAL ALLIANCE ON MENTAL ILLNESS
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate
Health Issues, Budget/Appropriations, Telecommunications, Taxation/Internal Revenue Code
View →
Q1
ADVANCED POLICY CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $40,000.00 income
Health Issues
View →
Q1
HARMONY BIOSCIENCES for HARMONY BIOSCIENCES
1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · Senate
Pharmacy
View →
Q1
THE ALS ASSOCIATION for THE ALS ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Veterans
View →
Q1
HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate
Health Issues
View →
Q1
PUBLIC CITIZEN for PUBLIC CITIZEN
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Banking, Civil Rights/Civil Liberties, Computer Industry, Consumer Issues/Safety/Products
View →
Q1
AEGIS LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Health Issues
View →
Q1
E3 STRATEGIC CONSULTING GROUP for PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · $60,000.00 income
Pharmacy
View →
Q1
ELITE STRATEGIC SERVICES for CONSERVATIVES FOR PROPERTY RIGHTS
1st Quarter (Jan 1 - Mar 31) 2026 · South Carolina · House · Senate · $25,000.00 income
Copyright/Patent/Trademark, Health Issues, Labor Issues/Antitrust/Workplace, Taxation/Internal Revenue Code
View →
Q3
TODD STRATEGY GROUP for PFIZER INC.
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Tariff (miscellaneous tariff bills), Trade (domestic/foreign)
View →
Q2
TODD STRATEGY GROUP for PFIZER INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $20,000.00 income
Pharmacy, Tariff (miscellaneous tariff bills), Trade (domestic/foreign)
View →
2A
BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Animals, Budget/Appropriations
View →
3A
NOVARTIS for NOVARTIS
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
2A
NOVARTIS for NOVARTIS
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Labor Issues/Antitrust/Workplace, Budget/Appropriations, Copyright/Patent/Trademark, Health Issues
View →
2A
PERSONALIZED MEDICINE COALITION for PERSONALIZED MEDICINE COALITION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Budget/Appropriations
View →
4A
BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Animals, Budget/Appropriations
View →
Q4
THE ALS ASSOCIATION for THE ALS ASSOCIATION
4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate
Medicare/Medicaid, Budget/Appropriations, Health Issues, Veterans
View →
Q4
YC CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · $30,000.00 income
Health Issues, Copyright/Patent/Trademark
View →
Q4
TODD STRATEGY GROUP for NOVARTIS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View →
Q4
EMD SERONO, INC. for EMD SERONO INC
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Veterans, Defense, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q4
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q4
BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Animals, Budget/Appropriations
View →
4T
THE MCMANUS GROUP for EMD SERONO, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid
View →
Previous Page 3 of 12 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem